BioLife Solutions, Inc. Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount
BioLife Solutions, Inc. (BLFS) reported Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Notes
us-gaap:WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount · last filed 2022-03-31
- BioLife Solutions, Inc. warrant, down round feature, (increase) decrease in equity, amount for the quarter ending 2021-12-31 was $0.00.
- BioLife Solutions, Inc. warrant, down round feature, (increase) decrease in equity, amount for the quarter ending 2021-09-30 was $0.00.
- BioLife Solutions, Inc. warrant, down round feature, (increase) decrease in equity, amount for the quarter ending 2021-06-30 was $0.00.
- BioLife Solutions, Inc. warrant, down round feature, (increase) decrease in equity, amount for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- BioLife Solutions, Inc. warrant, down round feature, (increase) decrease in equity, amount for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- BioLife Solutions, Inc. warrant, down round feature, (increase) decrease in equity, amount for fiscal 2020 was $3.60M.
- BioLife Solutions, Inc. warrant, down round feature, (increase) decrease in equity, amount for fiscal 2019 was $0.00.
| Period end | Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount 3 month | Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount 6 month | Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount 9 month | Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 derived: sum of 2 quarters · filed 2022-03-31 | $0.00 derived: sum of 3 quarters · filed 2022-03-31 | $0.00 10-K · filed 2022-03-31 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | -$866.00K derived: sum of 4 quarters · filed 2022-03-31 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | -$866.00K derived: sum of 3 quarters · filed 2022-03-31 | -$866.00K derived: sum of 4 quarters · filed 2022-03-31 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-17 | -$866.00K derived: sum of 2 quarters · filed 2022-03-31 | -$866.00K derived: sum of 3 quarters · filed 2022-03-31 | -$866.00K derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-12-31 | -$866.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$866.00K derived: sum of 2 quarters · filed 2022-03-31 | -$866.00K derived: sum of 3 quarters · filed 2022-03-31 | $3.60M 10-K · filed 2022-03-31 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $4.47M 10-Q · filed 2021-11-15 | $21.91M derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 | $5.47M 10-Q · filed 2021-08-16 | $21.91M derived: sum of 3 quarters · filed 2022-03-31 | $23.04M derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-03-31 | $21.91M 10-Q · filed 2021-05-17 | $21.91M derived: sum of 2 quarters · filed 2022-03-31 | $23.04M derived: sum of 3 quarters · filed 2022-03-31 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $1.13M derived: sum of 2 quarters · filed 2022-03-31 | $0.00 10-K · filed 2022-03-31 | |
| 2019-09-30 | $1.13M 10-Q · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |